Not Yet RecruitingNot Applicable

Rapid Evacuation and Access of Cerebral Hemorrhage Registry

United States2,500 participantsStarted 2026-06

Plain-language summary

The goal of this observational study is to quantify the real-world effect of minimally invasive surgery (MIS) in patients with acute spontaneous supratentorial intracerebral hemorrhage.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Head CT demonstrating an acute, spontaneous, intracerebral hemorrhage * Hemorrhage volume ≥ 20 mLs * Minimally invasive surgical intervention performed within 7 days of hemorrhage Exclusion Criteria: * Ruptured aneurysm, arteriovenous malformation (AVM), vascular anomaly, moyamoya disease, venous sinus thrombosis, mass or tumor, hemorrhagic conversion of an ischemic infarct, recurrence of a recent ICH (\<1 year), as diagnosed with radiographic imaging * Infratentorial intraparenchymal hemorrhage, including midbrain, pontine, or cerebellum * Initial hospital arrival ≥ 24 hours after the onset of stroke symptoms * Last known normal is unknown * Historical Modified Rankin Score \> 4 * Known life-expectancy of less than 1 year prior to ICH * DNR or comfort measures only * Known pregnancy in female subjects * Inability or unwillingness of subject or legal guardian/representative to give written informed consent within 7 days of initial hospital arrival * Inability to meet follow up requiremen

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Modified Rankin Scale (mRS) at 180 Days

Timeframe: Day 180 from baseline (±14 days)

30-Day Mortality

Timeframe: Day 30 (±7 days)

Trial details

NCT IDNCT07651631

SponsorEmory University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2033-06

Contact for this trial

Alex Hall, DHSc

404-778-1585 alex.hall@emory.edu

View on ClinicalTrials.gov More Intracerebral Hemorrhage trials

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.